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Abstract
Background: The aim of this study was to investigate the effect of the decreased level of thyroid hormones on selected parameters of the 
oxidation/reduction balance by assessing the activity of antioxidant enzymes: superoxide dismutase (SOD), and glutathione peroxidase 
(GSH-Px); the level of antioxidant vitamins (A, C, and E); and the concentration of compounds reacting with thiobarbituric acid (TBARS).
Material and methods: Investigations involved 20 Belgian giant rabbits of both sexes. Hypothyroidism was induced by intragastric ad-
ministration of thiamizole. Before  this was done, blood was collected from the ear marginal vein (control group) and then the animals 
received thiamizole through an intragastric tube at a dose of 2 mg/kg b.w. for 21 days. Blood was collected again (the experimental group) 
and the following determinations were performed:
— in blood serum, the thyroid hormones T3, T4 and TSH;
— vitamin A, C and E blood serum concentrations;
— in erythrocytes, the concentration of compounds reacting with TBARS, SOD and GSH-Px.
Results: A 21-day exposure of rabbits to thiamazole (2 mg/kg b.w./24 h) resulted in a statistically significant decrease of TBARS, a decrease 
of SOD and GPH-Px activity and in a statistically insignificant decrease in the level of vitamins A, C and E.
Conclusions: Hypothyroidism decreases the level of erythrocytes oxidation/reduction balance by diminishing oxidative lip-
ids damage and by decreasing the activity of antioxidative enzymes, but not by changes in the level of antioxidant vitamins. 
(Pol J Endocrinol 2011; 62 (3): 220–223)
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Streszczenie
Wstęp: Celem badania była ocena wpływu zmniejszenia stężenia hormonów tarczycy na wybrane parametry równowagi oksydacyjno-re-
dukcyjnej przez badanie aktywności enzymów antyoksydacyjnych ( SOD, GSH-Px), stężenia witamin antyoksydacyjnych (A, C, E) oraz 
związków reagujących z kwasem tiobarbiturowym (TBARS).
Materiał i metody: Badania przeprowadzono na 40 królikach rasy olbrzym beligijski, obojga płci. Niedoczynność tarczycy wywołano 
dożołądkowym podawaniem thiamazolu. Przed podaniem thiamazolu pobrano krew żylną (grupa kontrolna), a następnie przez 21 dni 
zwierzęta otrzymywały dożołądkowo thiamazol w dawce 2 mg/kg mc. Po tym czasie ponownie pobierano krew (grupa badana) i oznaczano:
— stężenie hormonów tarczycy T3, T4 i TSH; 
— stężenie witamin A, C i E w surowicy;
— stężenie związków reagujących z kwasem tiobarbiturowym (TBARS) i aktywność dysmutazy ponadtlenkowej (SOD) i peroksydazy 
glutationowej (GPH-Px) w erytrocytach. 
Wyniki: Po 21 dniach dożołądkowego podawania królikom thiamazolu (2 mg/kg mc./24 h) stwierdzono statystycznie znamienne zmniej-
szenie stężenia TBARS, obniżenie aktywności SOD i GPH-Px oraz statystycznie nieznamienne obniżenie stężenia witaminy A, C i E.
Wnioski: Niedoczynność tarczycy obniża poziom równowagi oksydacyjno-redukcyjnej erytrocytów poprzez zmniejszenie oksydacyjnych 
uszkodzeń tłuszczów oraz zmniejszenie aktywności enzymów antyoksydacyjnych, a nie poprzez zmiany w stężeniu witamin antyoksy-
dacyjnych. (Endokrynol Pol 2011; 62 (3): 220–223)
Słowa kluczowe: wolne rodniki tlenowe, antyoksydanty, niedoczynność tarczycy 
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Introduction
In mammals, thyroid hormones are humoral factors 
controlling the basal metabolism. They play a crucial 
role in the regulation of synthesis and degradation 
of proteins, vitamin A, E and b-caroten metabolism, 
tissues sensitivity to catecholamines, antioxidant en-
zymes activity and, above all, oxidative changes in 
mitochondria; they determine oxygen consumption in 
the respiratory chain [1, 2]. Mitochondria are the main 
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source of reactive oxygen species (ROS) in an organism 
in physiological conditions owing to the chain of tissue 
oxidation, which is located in them. Electrons which 
leak from mitochondria from the respiratory chain 
cause a one-electron reduction of oxygen which leads 
to the formation of a superoxide anion radical, a very 
reactive form of oxygen. The magnitude of superoxide 
anion radical generation directly derives from oxygen 
consumption by mitochondria.
Hypothyroidism is a clinical entity caused by insuf-
ficient production of thyroid hormone by the thyroid 
gland. Depression of metabolism in hypothyroidism is 
described as decreased oxygen consumption and thus 
the production of ROS. Owing to that, hypothyroidism 
is believed to protect against damage caused by diffe-
rent active oxygen compounds [3, 4]. However, the data 
concerning the shift of the oxidation/reduction balance 
towards the latter in hypothyroidism is limited, and the 
topic remains controversial [5, 6].
The aim of our study was to investigate the effect 
of experimental hypothyroidism on elements of the 
oxidation/reduction barrier by determining:
— in red blood cells:
 a) activity of the antioxidant enzymes superoxide 
dismutase (SOD), and glutathione peroxidase 
(GSH-Px);
 b) concentration of compounds reacting with thio-
barbituric acid (TBARS);
— in blood serum:
 a) the content of antioxidant vitamins (A, C, and E).
Material and methods
Investigations involved 20 Belgian giant rabbits of both 
sexes, mean body weight 3.2 kg, fed with LSK fodder 
(standard granulated fodder). The animals were housed 
in animal quartering conditions (temperature 18oC, hu-
midity 55%) with free access to water. Hypothyroidism 
was induced by intragastric administration of thiamizole 
(Metizol-ICN Polfa/Rzeszów, Valeant). Before this, blood 
was collected from the ear marginal vein (control group) 
and then the animals received thiamizole through an in-
tragastric tube at a dose of 2 mg/kg b.w. for 21 days. Blood 
was collected again (the experimental group), and the 
following determinations were performed:
— the thyroid hormones T3 and TSH level by the 
MEIA method and T4 level by the FPIA method on 
immunochemical analyser (AxSYM, ABBOT) using 
ABBOT (IMX);
—  cholesterol level using Kone Pro biochemical ana-
lyser and Bio Merieux reagents;
—  in blood serum, vitamin A concentration by the Sel-
varaj and Sivakumar spectrofluorometric method [7, 
8], vitamin C concentration by the Benzie enzymatic 
method [9], and vitamin E concentration by the spec-
trofluorometric method according to Hashim [10];
—  in erythrocytes, concentration of compounds react-
ing with thiobarbituric acid (TBARS) according to 
Rice-Evans [11];
—  in erythrocytes, superoxide dismutase activity 
(SOD) with Ransod-Randox (cat. no. SD 125) and 
glutathione peroxidase activity (GSH-Px) with 
Ransel-Randox (cat. no. RS 505).
The results were subjected to statistical analysis: 
arithmetical mean and standard deviation were calculat-
ed. Where distribution was not normal, Mann-Whitney 
U test was used to calculate statistical significance.
The study protocol was approved by the Bioethics 
Committee No. 61/99.
Results 
The obtained results are presented in Tables I and II. 
Table 1 demonstrates the effect of 21-day administration 
of thiamizole at the dose of 2 mg/kg b.w. on TSH, T3 and 
T4 hormones and on cholesterol level in rabbits. A sig-
nificant increase of thyroid-stimulating hormone (TSH) 
p < 0.01 and decrease of triiodothyroxin (T3) p < 0.001 
and thyroxin (T4) p < 0.001 allowed a diagnosis of 
hypothyroidism. Moreover, the cholesterol level was 
found to increase statistically significantly (p < 0.001) 
by more than 55%. Table II demonstrates the effect of ex-
perimental hypothyroidism on the selected parameters 
of the oxidation/reduction balance. The concentration 
of substances reacting with thiobarbituric acid (TBARS) 
decreased significantly from 24.6 ± 4.5 to 15.3 ± 3.8 
µM/L (p < 0.01). Superoxide dismutase activity de-
creased significantly from 112.7 ± 6.4 to 85.7 ± 7.3 U/L, 
and similarly the activity of glutathione peroxidase 
decreased significantly from 90.8 ± 5.4 to 58.6 ± 5.6 U/L.
The concentrations of vitamins A, E and C decreased 
after thiamizole but did not differ statistically signifi-
cantly from those before the preparation administration. 
Discussion 
Decreased basal metabolism is a biochemical expo-
nent of hypothyroidism associated with the limitation 
of oxygen consumption by mitochondrial respiratory 
chain [1, 2]. The consequence is not only inhibition of 
the flow of electrons through the chain of tissue oxida-
tion, and decrease of oxidative phosphorylation, but 
also a decrease in the production of free radicals which 
are responsible for oxygen toxic activity. 
Some authors suggest that hypothyroidism protects 
tissues against accelerated lipid peroxidation, although 
the data concerning oxidation/antioxidation in hypothy-
roidism is incomplete and contradictory [3, 12]. Lipid 
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peroxidation is the most recognised free radical process 
in an organism. The notion is understood as the process 
of unsaturated fatty acids oxidation, in consequence of 
which peroxides of those acids are formed [13]. In carry-
ing out our own investigations into the decrease of lipid 
peroxidation, we estimated that the level of compounds 
reacting with thiobarbituric acid (TBARS) decreased by 
about 35% compared to the control group.
The results of other authors are controversial. 
Dariyerli et al. did not find any changes in the content 
of malonyldialdehyde in rats with thiamizole-induced 
hypothyroidism [14]. However, an increase of lipid per-
oxidation attributed to dislipidaemia has been observed 
in women with hypothyroidism and dislipidemia in in-
vestigations of oxidative stress [15]. Both qualitative and 
quantitative lipid disorders, hyperlipoproteinemia and 
hypercholesterolemia have been described for a long 
time in hypothyroidism [16]. In our study, cholesterol 
levels increased after the administration of thiamizole 
by 56.5% in relation to the control group. Constantini 
et al., testing the effect of different concentrations of 
thyroid hormones on low density lipoproteins, ob-
served an increase of lipid peroxidation which strictly 
correlated with the level of free thyroxin. In our study, 
thyroxin levels decreased significantly [17].
The organism system defence against reactive oxygen 
species called the ‘antioxidative barrier’ has two kinds of 
compounds: enzymatic and nonenzymatic. The enzy-
matic compounds include: superoxide dismutase (SOD), 
glutathione peroxidase (GSH-Px) and catalase (Cat). In 
our study, the decrease of thyroxin level by about 60% 
caused the decrease of lipid peroxidation index (TBARS) 
by about 35%, and decrease of SOD activity by about 
20% and GSH-Px by 35%. The data concerning SOD 
or GSH-Px activity in hypothyroidism is contradictory. 
Some authors have observed decreased SOD activity 
in hypothyroidism, particularly in peripheral tissues [6, 
18], while others have not noticed any changes [14, 19]. 
A similar situation prevails with GSH-Px activity. 
Some authors did not find significant differences in 
GSH-Px activity [14, 19], while others have reported 
an increase of this activity in hypothyroidism [15, 18, 20]. 
The latter results are rather surprising, because hydro-
gen peroxide is a substrate for GSH-Px. This product is 
generated (among others) in the reaction of superoxide 
anion radical dismutation catalyzed by SOD, thus the 
availability of substrate for GSH-Px will be limited when 
there is no SOD activity or it is decreased.
Vitamins E, A and C belong to major nonenzymatic 
components of the antioxidative barrier. Vitamin E is 
Table I. The level of TSH, T3, T4 and cholesterol in plasma of rabbits exposed to thiamizole (2 mg/kg b.w./24 h) for 21 days
Tabela I. Stężenie tyreotreopiny (TSH), trijodotyroniny (T3), tyroksyny (T4) oraz cholesterolu w osoczu królików poddanych 
działaniu metizolu (2 mg/kg mc./d.) 
Thiamizole
Before administration After administration
Thyroid-stimulating hormone (TSH) [mU/L] 0.63 ± 0.13 5.14 ± 1.03
Triiodothyroxin (T3) [nmol/L] 2.39 ± 0.48 1.44 ± 0.27
Thyroxin (T4) [nmol/L] 137.8 ± 6.79 57.40 ± 5.20
Cholesterol [mg/dl] 77.10 ± 10.50 120.67 ± 14.80
Table II. The effect of experimental hypothyroidism on selected parameters of the oxidation/reduction balance
Tabela II. Wpływ doświadczalnej hypotyreozy na wybrane parametry równowagi oksydacyjno-redukcyjnej
Parameter Thiamizole Statistical significance
Before After 
TBARS [μmol/L] 24.6 ± 4.5 15.3 ± 3.8 p < 0.01
SOD [U/L of PRBCc] 112.7 ± 6.4 85.7 ± 7.3 p < 0.001
GSHPx [U/L of PRBCc] 90.8 ± 5.4 58.6 ± 5.6 p < 0.001
Vitamin A [mg/L] 0.8 ± 0.2 0.7 ± 0.2 No
Vitamin E [mg/L] 6.5 ± 1.8 6.1 ± 2.1 No
Vitamin C [mg/L] 4.2 ± 1.4 3.6 ± 1.1 No
PRBCc — packed red blood cells
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a mixture of tocopherols and tocotrienols. The differences 
between a, b, g and d tocopherols lie in the position of 
methyl groups in the chromane ring. Most cellular vita-
min E is located in membranes, mainly in the lipid layer 
[21]. The great effectiveness of vitamin E as an oxidant 
results from the fact that it can inhibit the oxidation proc-
ess at the initiation and the propagation stages [22]. In 
our study, the serum level of vitamin E after thiamizole 
administration decreased statistically insignificantly. 
However, there is data reporting an increase of vitamin 
E level in hypothyroidism parallel to an increase of MDA 
concentration, contradicting the thesis about the inhibi-
tion of peroxidation processes in hypothyroidism [23].
Similarly to vitamin E, carotens (a, b) and vitamin 
A (retinol) formed from b-carotene are hydrophobic anti-
oxidants. Carotens have been demonstrated to prevent 
oxidation of cell membrane lipids and serum lipoprotein 
fractions [24]. The antioxidant mechanism of carotens 
activity can be defined as three processes: extinction of 
factors initiating peroxidation processes; singlet oxygen 
scavenging; and scavenging and participation in peroxyl 
radicals decomposition [25]. The mean serum level of 
vitamin A in the control group of rabbits was 0.8 mg/l and 
after the administration of thiamizole it decreased statisti-
cally insignificantly. In the studies carried out by Aktuna 
et al., retinol levels did not differ statistically significantly 
in hypothyreosis, hyperthyreosis or euthyreosis [26]. It 
should be added that vitamin A has a multi-level effect 
on thyroid hormones production [27].
Vitamin C (ascorbic acid) demonstrates hydrophilic 
properties, and owing to strong reductive properties 
it is considered to be the main antioxidative factor of 
the aqueous phase, although it can equally easily react 
with lipid peroxides [28]. Primates, human beings and 
guinea pigs have lost the ability to synthesise ascorbic 
acid because of  the loss of the end enzyme of the 
ascorbate biosynthetic pathway gluconolactone oxidase 
(E.C.1.1.3.8). This is why they are dependent on ascor-
bate intake with their food. The rabbits’ serum level of 
vitamin C after thiamizole decreased insignificantly in 
relation to the control group. It could have been caused 
by the relatively short half-life of vitamin C (in humans 
it is 10–20 days) [29]. On the other hand, Moncayo et al. 
found decreased levels of vitamin C in hyperthyroidism, 
hypothyroidism, carcinoma and thyroiditis [30].
Conclusions
Hypothyroidism decreases the level of erythrocytes 
oxidation/reduction balance by diminishing oxidative 
lipids damage and by decreasing the activity of anti-
oxidative enzymes, but not by changes in the level of 
antioxidant vitamins. 
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